4-CN-BINACA-ADB

Description

Pharmacokinetics:

4-CN-BINACA-ADB is an indazole-3-carboxamide-based synthetic cannabinoid closely related to other indazole-based synthetic cannabinoids. Originally in development as painkillers, indazole synthetic cannabinoids are potent CB1 cannabinoid receptor agonists due to their indazole core [1, 2]. 4-CN-BINACA-ADB takes the form of a yellow crystalline powder. While it hasn’t been studied by medical researchers or reported about in medical journals, anecdotal evidence suggests the chemical becomes active at as low a dose as 0.1 mg.

Scientific Studies:

No studies on this particular chemical have been done to date. However, research suggests that indazole-3-carboxamide-based synthetic cannabinoids are up to 3 times more potent than indole-based synthetic cannabinoids, such as JWH-018 [2].

Sources:

1. https://link.springer.com/article/10.1007/s11419-018-0415-z

2. https://www.ncbi.nlm.nih.gov/pubmed/30280499/